• Represented Midatech Pharma, PLC, a publicly traded UK biopharmaceutical company, in its acquisition of DARA BioSciences, a publicly traded US biosciences company, and its registration of ordinary shares with the SEC and listing on the NASDAQ Capital Market, as well as in subsequent public and private securities offerings.
• Represented a $250 million Cayman-based SPAC in its pending initial public offering.
• Advised Arix Bioscience Plc, a global health care and life sciences company that sources, finances, and develops both start-up and later stage companies across the health care and life sciences sectors, on its initial public offering (IPO) and admission to trading on the standard segment of the Main Market of the London Stock Exchange. Arix, headquartered in London with an office in New York, raised total gross proceeds of £100 million in its oversubscribed IPO.
• Represented TESARO Inc., a Massachusetts-based pharmaceutical company, in connection with its $81 million initial public offering of common stock.
• Represented Apple Inc. in connection with its $17 billion offering of fixed and floating rate notes — at the time one of the largest corporate bond offerings in history.
• Represented S1 Corporation in its $516 million acquisition by ACI Worldwide, Inc.
• Represented STR Holdings, Inc., an NYSE-listed solar company, in connection with a sale of 51% of the company to a Chinese strategic partner.
• Represented National Rural Utilities Cooperative Finance Corporation in connection with its $512 million Rule 144A exchange offer and subsequent registered exchange offer.
• Represented Chicopee Bancorp, Inc. in connection with its conversion into the bank holding company form of organization and subsequent $101.8 million offering of common stock.
• Represented Webster Financial Corporation in connection with its $126.5 million registered offering of depositary shares.

* Transactions conducted by Jason prior to joining Mintz.